Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2006-11-28
2006-11-28
Lambkin, Deborah C. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S487000, C514S513000, C564S074000, C564S086000, C564S099000
Reexamination Certificate
active
07141609
ABSTRACT:
α- and β-amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
REFERENCES:
patent: 4450164 (1984-05-01), Bristol et al.
patent: 4477441 (1984-10-01), Boger et al.
patent: 4514391 (1985-04-01), Gordon et al.
patent: 4548926 (1985-10-01), Matsueda et al.
patent: 4599198 (1986-07-01), Hoover
patent: 4616088 (1986-10-01), Ryono et al.
patent: 4668769 (1987-05-01), Hoover
patent: 4668770 (1987-05-01), Boger et al.
patent: 4757050 (1988-07-01), Natarajan et al.
patent: 4826815 (1989-05-01), Luly et al.
patent: 4880938 (1989-11-01), Freidinger
patent: H725 (1990-01-01), Gordon
patent: 4963530 (1990-10-01), Hemmi et al.
patent: 4977277 (1990-12-01), Rosenberg et al.
patent: 5585397 (1996-12-01), Tung et al.
patent: 5723490 (1998-03-01), Tung
patent: 5744481 (1998-04-01), Vazquez et al.
patent: 5786483 (1998-07-01), Vazquez et al.
patent: 5830897 (1998-11-01), Vazquez et al.
patent: 5843946 (1998-12-01), Vazquez et al.
patent: 5856353 (1999-01-01), Tung et al.
patent: 5968942 (1999-10-01), Vazquez et al.
patent: 5977137 (1999-11-01), Tung et al.
patent: 6046190 (2000-04-01), Vazquez et al.
patent: 6060476 (2000-05-01), Vazquez et al.
patent: 6172082 (2001-01-01), Vazquez et al.
patent: 6248775 (2001-06-01), Vazquez et al.
patent: 6335460 (2002-01-01), Vazquez et al.
patent: 6417387 (2002-07-01), Vazquez et al.
patent: 6455581 (2002-09-01), Vazquez et al.
patent: 6472407 (2002-10-01), Vazquez et al.
patent: 6500832 (2002-12-01), Vazquez et al.
patent: 6534493 (2003-03-01), Vazquez et al.
patent: 6646010 (2003-11-01), Vazquez et al.
patent: 6846954 (2005-01-01), Vazquez et al.
patent: 6890942 (2005-05-01), Walker et al.
patent: 6943170 (2005-09-01), Carini
patent: 6958331 (2005-10-01), Brain et al.
patent: A 79823/87 (1988-04-01), None
patent: 104041 (1984-03-01), None
patent: 114993 (1984-06-01), None
patent: 172347 (1986-02-01), None
patent: 223437 (1987-05-01), None
patent: 0 264 795 (1988-04-01), None
patent: 337714 (1989-10-01), None
patent: 0 342 541 (1989-11-01), None
patent: 0 346 847 (1989-12-01), None
patent: 356223 (1990-02-01), None
patent: 389898 (1990-10-01), None
patent: 393445 (1990-10-01), None
patent: 393457 (1990-10-01), None
patent: 402646 (1990-12-01), None
patent: 468641 (1992-01-01), None
patent: 2 184 730 (1987-07-01), None
patent: 2 200 115 (1988-07-01), None
patent: 2 209 752 (1989-08-01), None
patent: WO 84/03044 (1984-08-01), None
patent: WO 92/00750 (1992-01-01), None
patent: WO 92/08699 (1992-05-01), None
patent: WO 94/04492 (1994-03-01), None
patent: WO 94/05639 (1994-03-01), None
patent: WO 99/33792 (1999-04-01), None
Roberts et al, “Rational Design of Peptide-based Proteinase Inhibitors,”Science, 248, 358 (1990).
Erickson et al, “Design Activity and 2.8A Crystal Structure of a C2Symmetric Complexed to HIV-1 Protease,”Science, 249, 527 (1990).
Pearl et al, “Sequence specificity of retroviral proteases,”Nature, 328 (1987).
Martin,Drugs of the Future, 16(3), 210-212 (1991).
Meek et al,Letter to Nature, 343, 90-92 (1990).
McQuade et al, “A Synthetic HIV-1 Protease Inhibitor with Antiviral Activity Arrests HIV-like Particle Maturation,”Science, 247, 454-456 (1990).
Rich et al, “Peptide Inhibitors of Proteases,”Design of Protease Inhibitors511-520 (1984).
Rosenberg et al,J. Med. Chem., 30, 1224-1228 (1987).
Bertenshaw Deborah E.
DeCrescenzo Gary A.
Freskos John N.
Getman Daniel P.
Heintz Robert M.
G.D. Searle & Co.
Lambkin Deborah C.
LandOfFree
α- and β-amino acid hydroxyethylamino... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with α- and β-amino acid hydroxyethylamino..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and α- and β-amino acid hydroxyethylamino... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3670486